| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
1 company
Sullivan Timothy Eugene is a Chief Financial Officer at Apellis Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 1 buy and 12 sells.
Estimated insider holdings value: $6.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 29, 2024 | APLS Apellis Pharmaceuticals, Inc. | Chief Financial Officer | Sell | 906 | $64.14 | $58,109.21 | -0.9% | -26.8% | -55.2% | |
| Jan 22, 2024 | APLS Apellis Pharmaceuticals, Inc. | Chief Financial Officer | Sell | 3,551 | $65.00 | $230,800.80 | -3.6% | -27.2% | -54.0% | |
| Jan 16, 2024 | APLS Apellis Pharmaceuticals, Inc. | Chief Financial Officer | Sell | 2,235 | $66.81 | $149,317.22 | -2.2% | -22.3% | -56.2% | |
| Nov 30, 2023 | APLS Apellis Pharmaceuticals, Inc. | Chief Financial Officer | Sale+OE | 14,158 | $54.73 | $774,884.32 | -8.3% | +18.9% | -37.0% | |
| Jul 3, 2023 | APLS Apellis Pharmaceuticals, Inc. | Chief Financial Officer | Sale+OE | 6,779 | $89.97 | $609,928.12 | -2.8% | -58.4% | -60.8% | |
| Jun 5, 2023 | APLS Apellis Pharmaceuticals, Inc. | Chief Financial Officer | Sale+OE | 69,779 | $88.80 | $6,196,526.86 | -13.5% | -52.0% | -55.6% | |
| Aug 29, 2019 | APLS Apellis Pharmaceuticals, Inc. | Chief Financial Officer | Buy | 11,699 | $29.71 | $347,629.94 | New | - | - |